Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Breast cancer screens scrutinised

19.10.2001


Mammography screening may not stand up to scrutiny.
© SPL


Study questions whether mammography saves lives.

Breast-cancer screening programmes may not save lives, according to a new examination of clinical trials. The controversial findings have led to calls for a re-evaluation of the routine monitoring procedure undergone by numerous women.

Mammography, X-ray breast imaging, is used in Europe and the United States to catch cancers early. "We’ve based a national screening programme on a set of results which do not stand up to scrutiny," says Richard Horton, editor of The Lancet, the medical journal that today publishes the peer-reviewed research.



In January 2000, Ole Olsen and Peter Gotzsche of the Nordic Cochrane Centre in Copenhagen, Denmark first questioned whether regular screening of middle-aged women reduces the overall cancer death rate1. Their challenging re-analysis of large-scale mammography trials sparked public and medical controversy as some questioned the validity of the work.

Now Olsen and Gotzsche have confirmed their earlier conclusions with a more comprehensive analysis2,3. The report comes with further scientific backing from the respected Cochrane Collaboration, an independent, international body that supports high-quality, systematic reviews of health-care treatments. "The best evidence says there is no reduction in mortality following screening," says Olsen.

Horton thinks that the "storm of protest" triggered by the initial report was understandable but subjective. "Everyone wants screening mammography to be a great success," he says. We should not be afraid to put medical procedures under the same scrutiny as any political decision, he argues.

"There is an urgency for the data to be re-analysed correctly," says breast-cancer clinician Serge Rozenberg of the Free University of Brussels in Belgium, and for women to be informed of existing doubts over the efficacy of screening. "This is about millions of women," he says; not acting on this study is "unacceptable".

But some still dispute Olsen and Gotzsche’s techniques and findings. "We estimate that screening is saving on average 1,250 lives a year," says Julietta Patnick, National Coordinator of the UK’s National Health Service breast-screening programme, which aims to examine all women over 50 every 3 years.

A bumpy ride

Around 1 in 8 women in the United States and 1 in 11 in Britain will develop breast cancer during their lives. It is the main cause of female cancer deaths in these countries for women under 54.

Mammography detects small changes in breast tissue that may indicate the beginnings of a tumour; results influence how doctors proceed. Treatment usually involves surgery to remove the abnormal tissue or the whole breast, followed by radiotherapy, chemotherapy or hormone therapy.

Olsen and Gotzsche reviewed seven clinical trials carried out since the 1960s in Europe, the United States and Canada, involving half-a-million women. The studies reported an average 30% reduction in mortality.

But the pair report that several studies were flawed, for example because women were not properly assigned at random to groups with or without screening. In the two best trials, Olsen and Gotzsche conclude that screening produced no reduction in overall death rate.

They calculate that in some trials, lives lost for other reasons outweighed the reduction in deaths due to breast cancer. Deaths in a screened group may be less likely to be ascribed to breast cancer, speculates Olsen - deaths may be "relabelled", he says.

Screened women were also more likely to undergo aggressive treatment. Some of this may have been unnecessary, say the authors - some tissue changes are benign or slow-growing and would not put lives at risk. Treatment also creates its own problems - for example, radiotherapy leads to an increased chance of heart disease.

References
  1. Gotzsche, P.C. & Olsen, O. Is screening for breast cancer with mammography justifiable?. The Lancet, 355, 129 - 134, (2000).

  2. Olsen, O. & Gotzsche, P.C. Cochrane review on screening for breast cancer with mammography. The Lancet, 358, 1340 - 1342 , (2001).

  3. Olsen, O. & Gotzsche, P.C.Screening for breast cancer with mammography. Cochrane Library, issue 4, Oxford: Update Software, in press (2001).

HELEN PEARSON | Nature News Service
Further information:
http://www.nature.com/nsu/011025/011025-5.html
http://www.nature.com/nsu/

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>